Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. EPS 2024–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly eps history and growth rate from 2024 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Cyclacel Pharmaceuticals, Inc. eps for the quarter ending March 31, 2026 was $0.04.
- Cyclacel Pharmaceuticals, Inc. annual eps for 2025 was $6.45, a 98.71% decrease from 2024.
- Cyclacel Pharmaceuticals, Inc. annual eps for 2024 was $501.60.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Cyclacel Pharmaceuticals, Inc. EPS — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) eps over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclacel Pharmaceuticals, Inc.'s eps?
Cyclacel Pharmaceuticals, Inc. (BGMS) reported eps of $-6.45 for fiscal 2025.
Where can I see BGMS's eps history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s eps by year and by quarter, including the growth rate.